In a recent US study presented at SBI 2021, MammoScreen® found 27% of the cancer cases one year earlier and 21% 2 years earlier, with a minimal increase in recall rate.
We invite you to discover our 2 posters:
Artificial Intelligence for Digital Breast Tomosynthesis: a tool to enhance radiologist’s performance and efficiency Learn +
Reducing false-positive recalls by adding temporal changes information to an AI system for breast cancer detection Learn +
Experience the POWER of MammoScreen®
Easy to integrate into your workflow. Take 10 minutes for a demo, and see what it’s like to have MammoScreen® AI at your side.
